REG - Directa Plus PLC - Update on Funding

Directa PlusAnnouncement

Yesterday 07:00

For best results when printing this announcement, please click on link below:
https://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20260330:nRSd5969Ya&default-theme=true

RNS Number : 5969Y  Directa Plus PLC  30 March 2026

The information communicated within this announcement is deemed to constitute
inside information as stipulated under the Market Abuse Regulations (EU) No.
596/2014 as it forms part of UK domestic law by virtue of the European Union
(Withdrawal) Act 2018 ("MAR"), and is disclosed in accordance with the
Company's obligations under Article 17 of MAR. Upon the publication of this
announcement, this inside information is now considered to be in the public
domain.

30 March 2026

 

Directa Plus plc

("Directa Plus", the "Group" or the "Company")

 

Update on Funding

 

Directa Plus (AIM: DCTA), a leading producer and supplier of graphene
nanoplatelets based products for use in consumer and industrial markets
announces that it is in advanced discussions with an institutional investor
for the provision of an up to £2.5m funding facility ("Proposed Facility") to
extend the Company's cash runway. At this time there can be no certainty that
any funding transaction will be concluded.

 

Further to the notification of 27 February 2026, the Company has not been able
to conclude its discussions with Nant Capital, LLC with regards to the terms
of a non-dilutive potential loan (the "Potential Loan").

 

The Proposed Facility would be subject to shareholder approval and if no
additional funding is secured, it is highly likely that this will result in
the Company and the Group not being a going concern and the Directors having
to take steps to place the Company into administration.

 

As announced on 7 January 2026, the Group closed FY25 with gross cash balances
of €1.5m (FY24: €4.98m), which provided an effective cash runaway into
early May 2026 and therefore needed to secure additional funding in FY26 to
support the business, hence the discussions regarding the Potential Loan and
the Proposed Facility.

 

The Board is continuing to progress both the potential sale of non-strategic
land held by its Romanian subsidiary Setcar SA, with an estimated value of at
least €0.5m, as well as evaluating options for the business, including
Setcar's disposal. The Board is continuing to implement the previously
announced cost containment and cost reduction initiatives, including its
workforce reduction programme at Setcar. The Italian company, Directa Plus SpA
continues its costs reduction actions.

 

Further information will be provided in due course.

 

This announcement has been approved by Giulio Cesareo, Chief Executive, on
behalf of the Company.

 

For further information, please contact:

 

 Directa Plus plc                                       +39 02 36714458
 Giulio Cesareo, CEO

 Singer Capital Markets (Nominated Adviser and Broker)  +44 20 7496 3069
 Rick Thompson / Phil Davies/Carl Diebitsch

 Alma Strategic Communications (Financial PR Adviser)   +44 20 3405 0205
 Justine James / Hannah Campbell / Rose Docherty        directaplus@almastrategic.com

 

About Directa Plus

Directa Plus (www.directa-plus.com (http://www.directa-plus.com/) ) is one of
the largest producers and suppliers of graphene-based products for use in
consumer and industrial markets. The Company's graphene manufacturing
capability uses proprietary patented technology based on a plasma super
expansion process. Starting from natural graphite, each step of Directa
Plus's production process - expansion, exfoliation and drying - creates
graphene-based materials and hybrid graphene materials ready for a variety of
uses and available in various forms such as powder, liquid and past.

 

This proprietary production process uses a physical process, rather than a
chemical process, to process graphite into pristine graphene nanoplatelets,
which enables Directa Plus to offer a sustainable, non-toxic product,
without unwanted by-products. Directa Plus's products are made of hybrid
graphene materials and graphene nano-platelets. The products (marketed as
G+®) have multiple applications due to its properties. These G+® products
can be categorised into various families, with different products being
suitable for specific practical applications.

 

Directa Plus was established in 2005 and is based in Lomaz (Como, Italy) and
has been listed on the AIM market of the London Stock Exchange since May
2016. The Company holds the Green Economy Mark from London Stock
Exchange which recognises companies that contribute to the global green
economy.

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
 or visit
www.rns.com (http://www.rns.com/)
.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
.   END  MSCSDFSISEMSEDD



            Copyright 2019 Regulatory News Service, all rights reserved